Short Interest in First Trust Bloomberg R&D Leaders ETF (NYSEARCA:RND) Decreases By 40.9%

First Trust Bloomberg R&D Leaders ETF (NYSEARCA:RND) was the recipient of a large decrease in short interest in August. As of August 14th, there was short interest totaling 11,936 shares, a decrease of 40.9% from the July 30th total of 20,185 shares. Approximately 4.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 5,959 shares, the days-to-cover ratio is presently 2.0 days.

Hedge Funds Weigh In On First Trust Bloomberg R&D Leaders ETF

Several large investors have recently modified their holdings of RND. Jane Street Group LLC bought a new stake in First Trust Bloomberg R&D Leaders ETF in the fourth quarter worth $627,000. IFP Advisors Inc raised its stake in shares of First Trust Bloomberg R&D Leaders ETF by 42.9% in the fourth quarter. IFP Advisors Inc now owns 6,528 shares of the company’s stock valued at $198,000 after acquiring an additional 1,960 shares during the period. Finally, International Assets Investment Management LLC bought a new stake in shares of First Trust Bloomberg R&D Leaders ETF in the 4th quarter worth about $140,000.

First Trust Bloomberg R&D Leaders ETF Stock Performance

RND remained flat at $33.08 on Monday. The company had a trading volume of 1,568 shares, compared to its average volume of 2,576. The firm has a market cap of $9.92 million, a P/E ratio of 34.30 and a beta of 1.24. First Trust Bloomberg R&D Leaders ETF has a 12 month low of $26.25 and a 12 month high of $33.68. The company’s 50-day moving average is $32.15 and its two-hundred day moving average is $30.70.

About First Trust Bloomberg R&D Leaders ETF

The First Trust Bloomberg R&D Leaders ETF (RND) is an exchange-traded fund that is based on the Bloomberg R&D Leaders Select TR index. The fund tracks a market cap-weighted index of 30-50 US stocks with substantial expenditures dedicated to research and development. RND was launched on Apr 30, 2024 and is issued by First Trust.